0001179110-14-010047.txt : 20140624 0001179110-14-010047.hdr.sgml : 20140624 20140609204731 ACCESSION NUMBER: 0001179110-14-010047 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140602 FILED AS OF DATE: 20140609 DATE AS OF CHANGE: 20140609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRIEDMAN CATHY CENTRAL INDEX KEY: 0001411874 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 14900406 MAIL ADDRESS: STREET 1: C/O XENOPORT, INC. STREET 2: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2014-06-02 2014-06-04 0 0001080014 THERAVANCE INC THRX 0001411874 FRIEDMAN CATHY THERAVANCE, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2014-06-02 4 A 0 7585 0 A 7585 D Common Stock 2014-06-02 4 A 0 7585 0 A 15170 D Stock Option (Right to Buy) 23.0786 2014-06-02 4 A 0 7585 0 A 2024-06-01 Common Stock 7585 7585 D Stock Option (Right to Buy) 23.0786 2014-06-02 4 A 0 7585 0 A 2024-06-01 Common Stock 7585 7585 D The number of shares was adjusted by a factor to account for the effect of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. The factor was based on the 3-day post-spin volume weighted average price of Theravance, Inc, and Theravance Biopharma, Inc. and the stock dividend of one ordinary share of Theravance Biopharma, Inc. for every 3.5 shares of Theravance, Inc. common stock received by Theravance, Inc. stockholders as of the record date for the spin-off. This option may be exercised and shall be vested as to 1/24th of the shares subject to this option when optionee completes each continuous month of service following the grant date. This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's stockholders provided the optionee remains in continuous service on such date. Heather M. Shane, Attorney-in-Fact 2014-06-09